Drug Eluting Stents - A Panacea?
Article Sidebar
Main Article Content
Abstract
Stents have taken care of many of the acute threatening complications and have opened a new demension in interventional cardiology. However restenosis remains a monster to the conquered and remains the Achilles heel of angioplasty. Restenosis is essentially due to recoil and neointimal hyperplasia (NIH). Where as recoil has yielded to the metalic scaffolding. Neointimal hyperplasia remains unconquered. Restenosis rates after stenting are thought to be between 15 and 25%. While this is clearly better than the rates after balloon angioplasty, the rates may be much higher in less than ideal settings.
Article Details
How to Cite
1.
Hafizullah M, Hassan M ul. Drug Eluting Stents - A Panacea?. J Postgrad Med Inst [Internet]. 2011 Sep. 22 [cited 2024 Nov. 25];16(1). Available from: https://jpmi.org.pk/index.php/jpmi/article/view/1187
Issue
Section
Review Article
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.